Navigation Links
5i Sciences Announces Appointment of a Senior Healthcare Consultant and Successful Financing
Date:7/22/2014

San Diego, CA (PRWEB) July 22, 2014

5i Sciences, a medical technology company focused on airway management products, announced the appointment of Molly Coye, M.D., M.P.H. to a role as Senior Consultant. Dr. Coye is an internationally renowned authority on the market introduction of innovative technologies that impact healthcare delivery. It is expected that she will advise on strategies for building a successful commercial healthcare enterprise based on the Company’s proprietary cNEP® technology. Dr. Coye is currently the Chief Innovation Officer of UCLA Health, and serves as a Director of Aetna, Inc. and Prosetta Biosciences, Inc. She founded and was CEO of the Health Technology Center, a preeminent forecaster of the impact of emerging technologies. She is a member of the prestigious Institute of Medicine and co-authored two landmark Institute reports on healthcare quality.

“The appointment of a Senior Consultant of Dr. Coye’s stature is an important achievement and opportunity for our Company,” said Dr. Richard Rose, President and CEO. “Given her extensive experience in evaluating emerging healthcare technologies, it is gratifying that she has chosen to work with 5i, which is further validation of the potential of our cNEP® technology for improving healthcare. We are delighted to have the opportunity to work closely with Dr. Coye as we identify strategies for maximizing the impact of our cNEP® products as they are introduced into the markets for hospital based airway management and sleep medicine.”

Dr. Coye commented, “I am very pleased to have the opportunity to advise 5i Sciences in the further development of their technology and products, because they target some of the most clinically important and widespread conditions affecting patients. The potential of the cNEP technology for improving outcomes and patient experience in both hospital and home settings is very promising.”

The Company also announced completion of a Series B financing that raised $2.5 million and resulted in the conversion of $2.9MM in convertible Notes, $2 MM of which, was previously announced. Dr. Rose indicated that these funds will be used to further the development of products for airway management in anesthesia care and sleep medicine.

Avram Miller, Vice-Chairman, remarked “Over the last twelve months, 5i Sciences has made significant progress in strengthening its board and management team, and advancing the development of its core technology. The more than five million dollars that the company has raised provides a solid financial foundation which will allow the company to bring its first products to market.”

About 5i Sciences:
5i Sciences is developing its proprietary continuous negative external pressure (cNEP®) technology for important medical and consumer applications. The Company is dedicated to offering simple to use, safe and well-tolerated products that keep the upper airway open. For more information, visit http://www.5iSciences.com.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12035379.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Western University of Health Sciences Elevated to “Great College to Work For” Honor Roll
2. NSU’s Graduate School of Computer and Information Sciences to Hold Special Presentations on Top 5 Technology Trends to Impact Business & IT Leaders
3. California Healthcare Institute Adds Executives from Gilead Sciences, Cedars-Sinai and Versant Ventures to Its Board
4. Miraca Life Sciences’ PathConnect System Achieves ONC HIT 2014 Edition Modular EHR Certification from ICSA Labs
5. UMMS scientist named 2014 Pew Latin American Fellow in the biomedical sciences
6. St. Jude Childrens Research Hospital scientist elected to National Academy of Sciences
7. BIDMCs Martin Pollak, M.D., elected to National Academy of Sciences
8. Wyss Institute Core Faculty member elected to the National Academy of Sciences
9. Norwegian neuroscientists elected to National Academy of Sciences
10. Miraca Life Sciences Announces Significant Tradeshow Plans for the Annual Meeting of the American Academy of Dermatology
11. Helping Children with Autism Using Brain Training Apps from C8 Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD is dual ... City. He is known for his distinguished expertise and experience in the diagnosis and ... sub-specialty training in treating renovascular disease and aortic aneurysm . He is known ...
(Date:5/24/2017)... ... May 24, 2017 , ... NucleusHealth ... interpretation, has received U.S. Food and Drug Administration (FDA) 510(k) clearance ... and secure cloud platform for medical image management. At the core is patented ...
(Date:5/24/2017)... ... 2017 , ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now ... a referral. Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take ... Patients no longer need to feel the esthetic effects of wires and brackets when ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... Policy Solutions is vehemently opposed to Donald Trump’s budget, “A New Foundation for ... that inspires fear, demonizes the poor, marginalizes underserved populations, undermines productivity, and destroys ...
(Date:5/24/2017)... ... May 24, 2017 , ... ... Course II of the HP3 (High-Performance Periodontal Practice) continuing education (CE) series. As ... latest advancements in his field by attending numerous CE courses each year. His ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... , May 9, 2017  Semler Scientific, Inc. ... technology solutions to improve the clinical effectiveness and ... for the first quarter ended March 31, 2017. ... enable our customers to identify when preventive care ... before events like heart attacks or strokes occur," ...
(Date:5/6/2017)... --  Provista , a proven leader in the supply chain ... Jim Cunniff as the company,s new president and ... to Provista, including most recently serving as the president and ... . He assumed his new role with Provista on May ... Provista," says Jody Hatcher , president, Sourcing and Collaboration ...
(Date:5/4/2017)... MONTREAL , May 4, 2017  Fortuna Fix Inc. (" ... aiming to be the first to eliminate the need for ... autologous cells to treat neurodegenerative diseases. Fortuna ... ("SAB") with Professor Michael Fehlings , MD, PhD; Father ... Hack , MD, MPH; and Professor James Giordano , ...
Breaking Medicine Technology: